The drug is well absorbed from the gastrointestinal tract, but more slowly than reserpine, so the hypotensive effect develops gradually.
Return with faeces approximately methenolone enanthate side effect 60% of the drug in the urine – 8%. The half-life of 45-168 hours.
Hypertension (mild to moderate).
Raunatin is contraindicated in case of hypersensitivity to the drug, hypotension, depression, failure of the coronary circulation, organic lesions of infarction, aortic defects, gastric ulcer and duodenal ulcers, nephrosclerosis, in the last trimester of pregnancy, age under 18 years old.
Dosing and Administration
Raunatin designate an adult, inside, after a meal.
Begin, as a rule, with the reception at night 1 tablet containing 0,002 grams (2 mg) total alkaloids; on day 2 and 1 tablet taken two times per day; on the 3rd day – 3 tablets, giving a total dose of up to 4-5-6 tablets per day. After the onset of effect (usually 10-14 days) methenolone enanthate side effect the dose was gradually reduced to 1-2 tablets per day. The course of treatment is 3-4 weeks, but in some cases by drug readings take a long time in a maintenance dose – 1 tablet per day.
Raunatin when properly selected dose usually does not cause side effects, but in some cases there is swelling of the mucous membranes of the nose, sweating, weakness, false angina, bradycardia, heart pain, depression, decreased libido. Side effects are eliminated by reducing the dose or after a short (1-3 days), the break in his reception.
Interaction with other drugs
Raunatin can be used simultaneously or sequentially with other antihypertensive agents (ganglioblokatorami, hydrochlorothiazide, hydralazine, etc.).
Be wary appointed in conjunction with quinidine, guanethidine, cardiac glycosides, beta-blockers (risk of increased severity of negative chrono and dromotropic action).
Raunatin able to enhance the effects methenolone enanthate side effect of alcohol and barbiturates on the central nervous system.
The safety and efficacy of raunatinom in children have not been established. There are no adequate and well-controlled studies of the effect of the drug on women in lactation was conducted.
Patients who continuously use the drug should avoid activities potentially hazardous activities that require increased attention and speed of mental and motor responses.